Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Raymond James Maintains Strong Buy on Xponential Fitness, Lowers Price Target to $20

Author: Benzinga Newsdesk | August 02, 2024 01:53pm
Raymond James analyst Joseph Altobello maintains Xponential Fitness (NYSE:XPOF) with a Strong Buy and lowers the price target from $30 to $20.

Posted In: XPOF

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist